News By: Emily Norris

Years of voracious M&A activity industry wide have inevitably taken a toll on any sense of stability among many in the drug development talent pool. Long-term job security, once the hallmark of the pharmaceutical industry, is no more. Many workers, especially highly skilled experts, want to practice their craft far more than they want the supposed trappings of management.

The Rosetta stone became an invaluable tool for deciphering the previously untranslatable hieroglyphic style of Ancient Egyptian script because the other languages used on the stone were already known to linguists. Today, clinical researchers can take advantage of a new tool offering something akin to the Rosetta stone’s breakthrough gift—a way to take feedback from clinical trial participants that is often collected but left unused and translate it into actionable data. 

While feedback from clinical trial participants that they would like their personal study data and overall trial results to be shared with them has been loud and clear for many years now, effective follow-through from sponsors and sites on such sentiments has historically been more muddled. However, recent advances in patient portal capabilities available through “middlemen” technology providers hold promise for breaking down the communication barriers and increasing transparency along the way.

In this article, we will explore the importance of sound financial practices for sites. We’ll also outline how utilizing a clinical trial management system (CTMS) that provides comprehensive financial management and adheres to Generally Accepted Accounting Principles (GAAP) can help ensure financial success.

In recognition of October being Breast Cancer Awareness Month, ACRP recently went behind the scenes with a clinical research coordinator on the study team for a bold Cleveland Clinic investigation of a vaccine aimed at preventing triple-negative breast cancer (TNBC), the most aggressive and lethal form of the disease.